Position in FTRE
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,844
+$846 QoQ
Shares Held
106
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#269
of 331 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hickory Point Bank & Trust holds $67,127 across 6 Biotechnology names. FTRE ranks #5 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
61 | $38,035 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
750 | $16,395 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
150 | $8,181 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4 | $1,986 | |
| 5 | FTRE |
Fortrea Holdings Inc.
This page
|
106 | $1,844 | |
| 6 | GMAB |
Genmab A/S
|
25 | $686 |
All Filings in FTRE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,844 | 106 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $998 | 106 | Shares | Sole | 2026-04-03 | |
| No filing history on record for this holder in this stock. | ||||||